Rolf Schulte‐Hermann
Impact in
- Hepatology top 0.5%
- Liver physiology and pathology
- Cancer Research top 0.5%
- Carcinogens and Genotoxicity Assessment
Papers in
- Hepatology 41
- Liver physiology and pathology 39
- Pharmacology 32
- Pharmacogenetics and Drug Metabolism 23
- Co-authors
- Wilfried BurschF OberhammerBettina Grasl‐KrauppI. Timmermann-TrosienerBranislav Ruttkay-NedeckýWolfram ParzefallMargit PavelkaJ. Schuppler
- Journals
- Carcinogenesis (18 papers)Archives of Toxicology (13 papers)Hepatology (10 papers)Naunyn-Schmiedeberg s Archives of Pharmacology (7 papers)Toxicologic Pathology (5 papers)
- Partner nations
- AustriaGermanyUnited States
In The Last Decade
Rolf Schulte‐Hermann
202 papers receiving 11.8k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Hepatology 1.6k
- Cancer Research 2.5k
- Pharmacology 1.3k
- Oncology 2.5k
- Molecular Biology 6.1k
Countries citing papers authored by Rolf Schulte‐Hermann
This map shows the geographic impact of Rolf Schulte‐Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Schulte‐Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Schulte‐Hermann more than expected).
Fields of papers citing papers by Rolf Schulte‐Hermann
This network shows the impact of papers produced by Rolf Schulte‐Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Schulte‐Hermann. The network helps show where Rolf Schulte‐Hermann may publish in the future.
Co-authors
The 25 scholars most cited alongside Rolf Schulte‐Hermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 9 | |
| 2 | 2012 | 29 | |
| 3 | 2011 | 59 | |
| 4 | 2007 | 64 | |
| 5 | 2006 | 35 | |
| 6 | 2005 | 71 | |
| 7 | 2004 | 29 | |
| 8 | 2003 | 65 | |
| 9 | 2002 | 35 | |
| 10 | 1996 | 249 | |
| 11 | 1995 | 61 | |
| 12 | [Relevance of apoptosis for carcinogenesis]. | 1994 | 2 |
| 13 | 1993 | 13 | |
| 14 | 1992 | 375 | |
| 15 | Mitogenesis and programmed cell death as determinants of carcinogenicity of nongenotoxic compounds. | 1991 | 7 |
| 16 | 1990 | 16 | |
| 17 | 1990 | 32 | |
| 18 | Relevance of N-nitroso compounds to human cancer : exposures and mechanisms : proceedings of the IXth International Symposium on N-nitroso Compounds, held in Baden, Austria, 1-5 September 1986 | 1987 | 5 |
| 19 | Proceedings: Control by feeding habits of the induction of hepatic DNA synthesis by alpha-hexachlorocyclohexane. | 1974 | 1 |
| 20 | 1974 | 292 |
About Rolf Schulte‐Hermann
Rolf Schulte‐Hermann is a scholar working on Hepatology, Pharmacology, Cancer Research, Biochemistry and Oncology, having authored 202 papers that have together received 12.2k indexed citations. Recurring topics across this work include Liver physiology and pathology (39 papers), Carcinogens and Genotoxicity Assessment (28 papers), Cell death mechanisms and regulation (28 papers), Pharmacogenetics and Drug Metabolism (23 papers), Liver Disease Diagnosis and Treatment (18 papers), Cancer-related Molecular Pathways (17 papers), Drug Transport and Resistance Mechanisms (16 papers) and TGF-β signaling in diseases (13 papers). The work is most often cited by research in Hepatology (1.6k citations), Cancer Research (2.5k citations), Pharmacology (1.3k citations), Oncology (2.5k citations) and Molecular Biology (6.1k citations). Rolf Schulte‐Hermann has collaborated with scholars based in Austria, Germany and United States. Frequent co-authors include Wilfried Bursch, F Oberhammer, Bettina Grasl‐Kraupp, I. Timmermann-Trosiener, Branislav Ruttkay-Nedecký, Wolfram Parzefall, Margit Pavelka, J. Schuppler, Siegfried Knasmüller and Christopher Gerner. Their work appears in journals such as Carcinogenesis, Archives of Toxicology, Hepatology, Naunyn-Schmiedeberg s Archives of Pharmacology and Toxicologic Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.